Registro:

Referencias:

• Rodgers, G.M., Endothelium and the regulation of hemostasis (1999) Wintrobe's Clinical Hematology., pp. 684-764. , Lee GR, Foerster J, Lukens JN, Paraskevas, Creer, Rodgers, editors. Baltimore, Md, USA: Lippincott Williams & Wilkins;
• Tracy, P.B., Role of platelets and leukocytes in coagulation (2001) Hemostasis and Thrombosis. Basic Principles and Clinical Practice., pp. 575-596. , Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN, editors. Philadelphia, LA, USA: Lippincott Williams & Wilkins;
• Colman, R.W., Clowes, A.W., George, J.N., Hirsh, J., Marder, V.J., Overview of hemostasis (2006) Hemostasis and Thrombosis. Basic Principles and Clinical Practice., pp. 3-20. , Colman RW, Clowes AW, Goldhaber SZ, Marder VJ, and George JN, editors. Philadelphia, LA, USA: Lippincott Wlliams & Wlkins;
• Mosesson, M.W., Fibrinogen and fibrin structure and functions (2005) J Thromb Haemost, 3, pp. 1894-1904
• Collen, D., The plasminogen (fibrinolytic) system (1999) Thromb Haemost, 82 (2), pp. 259-270
• Kolev, K., Machovich, R., Molecular and cellular modulation of fibrinolisis (2003) Thromb Haemost, 89, pp. 610-621
• Castellino, F.J., Ploplis, V.A., Structure and function of the plasminogen/plasmin (2005) Thromb Haemost, 93, pp. 647-654
• Gabriel, D.A., Muga, K., Boothroyd, E.M., The effect of fibrin structure in fibrinolysis (1992) J Biol Chem, 267, pp. 24259-24263
• Medved, L., Nieuwenhuizen, W., Molecular mechanisms of initiation of fibrinolysis by fibrin (2003) Thrombosis and Haemostasis, 89 (3), pp. 409-419
• Longstaff, C., Qough, A.M., Gaff Ney, P.J., Kinetic of plasmin activation of single chain urinary-type plasminogen activator (scu-PA) and demonstration of a high affinity interaction between scu-PA and plasminogen (1992) J Biol Chem, 267 (1), pp. 173-179
• Yarovaya, G.A., Blokhina, T.B., Neshkova, E.A., Contact system. New concepts on activation mechanism and bioregulatory functions (2002) Biochemistry, 67 (1), pp. 13-24
• Collen, D., Lijnen, H.R., Thrombolytic agents (2005) Thromb Haemost, 93, pp. 627-630
• Lijnen, H.R., Pleiotropic functions of plasminogen activator inhibitor-1 (2005) Journal of Thrombosis and Haemostasis, 3 (1), pp. 35-45. , DOI 10.1111/j.1538-7836.2004.00827.x
• Bjorquist, P., Ehnebom, J., Inghardt, T., Deinum, J., Epitopes on plasminogen activator inhibitor type-1 important for binding to tissue plasminogen activator (1997) Biochimica et Biophysica Acta - Protein Structure and Molecular Enzymology, 1341 (1), pp. 87-98. , DOI 10.1016/S0167-4838(97)00065-4, PII S0167483897000654
• Kruithof, E.K.O., Chien, T.-T., Gudinchet, A., Fibrinolysis in pregnancy: A study of plasminogen activator inhibitors (1987) Blood, 69 (2), pp. 460-466
• Medcalf, R.L., Stasinopoulos, S.J., The undecided serpin. the ins and outs of plasminógeno activator inhibitor type 2 (2005) FEBS J, 272, pp. 4858-4867
• Frank, P.S., Douglas, J.T., Locher, M., Llinas, M., Schaller, J., Structural/functional characterization of the α 2-plasmin inhibitor C-terminal peptide (2003) Biochemistry, 42 (4), pp. 1078-1085. , DOI 10.1021/bi026917n
• Wang, H., Yu, A., Wiman, B., Pap, S., Identification of amino acids in antiplasmin involved in its noncovalent 'lysine-binding-site'-dependent interaction with plasmin (2003) European Journal of Biochemistry, 270 (9), pp. 2023-2029. , DOI 10.1046/j.1432-1033.2003.03578.x
• Kimura, S., Aoki, N., Cross-linking site in fibrinogen for α 2-plasmin inhibitor (1986) Journal of Biological Chemistry, 261 (33), pp. 15591-15595
• Hart, J.P., Pizzo, S.V., α-Macroglobulins and kunins (2006) Hemostasis and Thrombosis. Basic Principles and Clinical Practice., pp. 395-407. , In Colman RW, Clowes AW, Goldhaber SZ, Marder VJ, George JN, editors. Philadelphia, LA, USA: Lippincott Williams & Wilkins;
• Mao, S.S., Cooper, C.M., Wood, T., Shafer, J.A., Gardell, S.J., Characterization of plasmin-mediated activation of plasma procarboxypeptidase B: Modulation by glycosaminoglycans (1999) Journal of Biological Chemistry, 274 (49), pp. 35046-35052
• Boffa, M.B., Bell, R., Stevens, W.K., Nesheim, M.E., Roles of thermal instability and proteolytic cleavage in regulation of activated thrombin-activable fibrinolysis inhibitor (2000) Journal of Biological Chemistry, 275 (17), pp. 12868-112378. , DOI 10.1074/jbc.275.17.12868
• Bouma, B.N., Marx, P.F., Mosnier, L.O., Meijers, J.C., Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U) (2001) Thrombosis Research, 101 (5), pp. 329-354. , DOI 10.1016/S0049-3848(00)00411-4, PII S0049384800004114
• Wight, T.N., Heinegard, D.K., Hascall, V.C., Proteoglycans. Structure and function (1991) Cell Biology of Extracellular Matrix., pp. 45-78. , Hay ED, editor. New York, USA: Plenum Press
• Fareed, J., Hoppensteadt, D., Walenga, J.M., Ahsan, A., Coyne, E., Breddin, H.K., Molecular and functional heterogeneity in dermatan sulfate preparations (1991) Sem Thromb Hemost, 17 (2), pp. 174-180
• Jaques, L.B., Glycosaminoglycans as polyelectrolites: Rejuvenation of original concepts (1991) Sem Thromb Hemost, 17, pp. 1-4
• Casu, B., Structural features and binding properties of chondroitin sulfates, dermatan sulfate, and heparan sulfate (1991) Sem Thromb Hemost, 17, pp. 9-14
• Hascall, V.C., Heinegard, D.K., Wight, T.N., Proteoglycans. Metabolism and pathology (1991) Cell Biology of Extracellular Matrix., pp. 149-175. , In Hay ED, editor. New York, USA: Plenum Press
• Kjellen, L., Lindahl, U., Proteoglycans: Structures and interactions (1991) Annu Rev Biochem, 60, pp. 443-475
• Bandtlow, C.E., Zimmermann, D.R., Proteoglycans in the developing brain: New conceptual insights for old proteins (2000) Physiol Rev, 80 (4), pp. 1267-1290
• Peplow, P.V., Glycosaminoglycan: A candidate to stimulate the repair of chronic wounds (2005) Thromb Haemost, 94, pp. 4-16
• Esmon, C.T., Protein C, protein S, and trombomodulina (2006) Hemostasis and Thrombosis. Basic Principles and Clinical Practice, pp. 335-353. , Colman RW, Clowes AW Goldhaber SZ, Marder VJ, George JN, editors. Philadelphia, LA, USA: Lippincott Williams & Wilkins
• Van Meijer, M., Smilde, A., Tans, G., Nesheim, M.E., Pannekoek, H., Horrevoets, A.J., The suicide substrate reaction between plasminogen activator inhibitor 1 and thrombin is regulated by the cofactors vitronectin and heparin (1997) Blood, 90 (5), pp. 1874-1882
• Casu, B., Naggi, A., Torri, G., Chemical derivatization as a strategy to study structure-activity relationships of glycosaminoglycans (2002) Seminars in Thrombosis and Hemostasis, 28 (4), pp. 335-342. , DOI 10.1055/s-2002-34302
• Huntington, J.A., Mechanism of glycosaminoglycan activation of serpins in hemostasis (2003) J Thromb Haemost, 1, pp. 1535-1549
• Tollefsen, D.M., Zhang, L., Heparin and vascular proteoglycans (2006) Hemostasis and Thrombosis. Basic Principles and Clinical Practice., pp. 271-283. , In Colman RW, Clowes AW, Goldhaber SZ, Marder VJ, George JN, editors. Philadelphia, LA, USA: Lippincott Williams & Wilkins;
• Bock, S.C., Antithrombin III and hepain cofator II (2006) Hemostasis and Thrombosis. Basic Principles and Clinical Practice., pp. 235-248. , In Colman RW, Clowes AW, Goldhaber SZ, Marder VJ, George JN, editors. Philadelphia, LA, USA: Lippincott Williams & Wilkins;
• Tollefsen, D.M., Majerus, D.W., Blank, M.K., Heparin cofator II. Purification and properties of a heparin-dependent inhibitor of thrombin in human plasma (1982) J Biol Chem, 257 (5), pp. 2162-2169
• Han, J.H., Cote, H.C., Tollefsen, D.M., Inhibition of meizothrombin and meizothrombin (desF1) by heparin cofactor II (1997) J Biol Chem, 272, pp. 28660-28665
• Tollefsen, D.M., Pestka, C.A., Monafo, W.J., Activation of heparin cofactor II by dermatan sulfate (1983) J Biol Chem, 258 (11), pp. 6713-6716
• Tollefsen, D.M., Insight into the mechanism of action of heparin cofactor II (1995) Thromb Haemost, 74 (5), pp. 1209-1214
• Bendayan, P., Boccalon, H., Dupouy, D., Boneu, B., Dermatan sulfate is a more potent inhibitor of clot-bound thrombin than unfractionated and low molecular weight heparins (1994) Thrombosis and Haemostasis, 71 (5), pp. 576-580
• Maimone, M.M., Tollefsen, D.M., Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity (1990) Journal of Biological Chemistry, 265 (30), pp. 18263-18271
• Rossi, E.B., Duboscq, C.L., Kordich, L.C., Cofactor II de la heparina(HC II), un inhibidor detrombinacuyo rol fisiológico no está completamente esclarecido (1999) Medicina, 59, pp. 95-104
• Tollefsen, D.M., Heparin cofactor II modulates the response to vascular injury (2007) Arteriosclerosis, Thrombosis, and Vascular Biology, 27 (3), pp. 454-460. , DOI 10.1161/01.ATV.0000256471.22437.88, PII 0004360520070300000007
• Andrew, M.A., Mitchell, L., Berry, L., Paes, B., Delorme, M., Ofosu, F., An anticoagulant dermatan sulfate proteoglycan circulates in pregnant woman and her fetus (1992) J Clin Invest, 89 (1), pp. 321-326
• Delorme, M.A., Saeed, N., Sevcik, A., Mitchell, L., Berry, L., Johnston, M., Andrew, M., Plasma dermatan sulfate proteoglycan in a patient on chronic hemodialysis (1993) Blood, 82 (11), pp. 3380-3385
• Rossi, E., Duboscq, C., Peragallo, M., Kordich, L., Heparin cofactor II (HC II) and dermatan sulfate plasmatic levels in acute burnt patients (1997) Thromb Haemost, p. 435. , Suppl
• Duboscq, C., Rossi, E., Quintana, I., Kordich, L., Actividad del cofactor II de la heparina y concentración de dermatan sulfato en pacientes sépticos (1994) Medicina, 54 (2-5), p. 509
• Prandoni, P., Meduri, F., Cuppini, S., Toniato, A., Zangrandi, F., Polistena, P., Dermatan sulphate: A safe approach to prevention of post operative deep vein thrombosis (1992) Br J Surg, 79, pp. 505-509
• Agnelli, G., Cosmi, B., Di Filippo, P., Ranucci, V., Veschi, F., Longetti, M., A randomized, double-blind, placebocontrolled trial of dermatan sulfate for prevention of deep vein thrombosis in hip fracture (1992) Thromb Haemost, 67, pp. 203-208
• Cohen, A.T., Phillips, M.J., Edmondson, R.A., Skinner, J.A., Das, S.K., Cooper, D.J., A dose ranging study to evaluate dermatán sulphate in preventing deep vein thrombosis following total hip arthroplasty (1994) Thromb Haemost, 72, pp. 793-798
• Di Carlo, V., Agnelli, G., Prandoni, P., Coccheri, S., Gensini, G.F., Gianese, F., Dermatan sulphate for the prevention of postoperative venous thromboembolism in patients with cancer (1999) Thrombosis and Haemostasis, 82 (1), pp. 30-34
• Attanasio, E., Russo, P., Carunchio, G., Caprino, L., Dermatan sulfate versus unfractionated heparin for the prevention of venous thromboembolism in patients undergoing surgery for cancer (2001) A Cost-effectiveness Analysis. Pharmacoeconomics, 19 (1), pp. 57-68
• Kretz, J., Chakfe, N., Wiesel, M.L., Grunebaum, L., Zamboni, V., Palazzini, E., The treatment of deep vein thrombosis with intravenous low-molecular-weight dermatan sulphate (Desmin) (1996) A Pilot Study. Thromb Res, 84 (6), pp. 391-398
• Von Kemp, K., Jochmans, K., Tussenbroek, F., Debruyne, H., Van Den Brande, P., Desmin (a low molecular weight dermatan sulphate) versus heparin in the treatment of patients with deep venous thrombosis (1998) European Journal of Clinical Pharmacology, 54 (2), pp. 133-139. , DOI 10.1007/s002280050434
• Taliani, M.R., Agnelli, G., Nenci, G.G., Gianese, F., Dermatan sulphate in patients with heparin-induced thrombocytopenia (1999) British Journal of Haematology, 104 (1), pp. 87-89. , DOI 10.1046/j.1365-2141.1999.01143.x
• Imberti, D., Verso, M., Silvestrini, E., Taliani, M.R., Agnelli, D., Successful treatment with dermatan sulfate in six patients with heparin-induced thrombocytopenia and acute venous thromboembolism (2003) J Thromb Haemost, 1, pp. 2696-2697
• Ryan, K.E., Lane, D.A., Flynn, A., Ireland, H., Boisclair, M., Shepperd, J., Antithrombotic properties of dermatan sulphate (MF 701 ) in haemodialysis for chronic renal failure (1992) Thromb Haemost, 68 (5), pp. 563-569
• Boccardo, P., Melacini, D., Rota, S., Mecca, G., Boleta, A., Casiraghi, F., Individualized anticoagulation with dermatan sulphate for haemodialysis in chronic renal failure (1997) Nephrol Dial Transplant, 12 (11), pp. 2349-2354
• Cofrancesco, E., Boschetti, C., Leonardi, P., Gianese, F., Cortellaro, M., Dermatan sulphate for the treatment of disseminated intravascular coagulation (DIC) in acute leukaemia: A randomised, heparin-controlled pilot study (1994) Thrombosis Research, 74 (1), pp. 65-75. , DOI 10.1016/0049-3848(94)90036-1
• Barbanti, M., Calanni, F., Babbini, M., Bergonzini, G., Parma, B., Marchi, E., Antithrombotic activity of Desmin 370 comparison with a high molecular weight dermatan sulphate (1993) Thromb Res, 71, pp. 417-422
• Ferrari, G.P., Marchesini, D., Maggi, A.P., Preliminary chemical, biochemical, and pharmacological characterization of a low molecular weight dermatan sulphate (1994) Carbohydrate Research, 255, pp. 125-132. , DOI 10.1016/S0008-6215(00)90974-1
• Fernandez, F., Van Ryn, J., Ofosu, F.A., Van Ryn, J., The haemorrhagic and antithrombotic effects of dermatan sulphate (1986) British Journal of Haematology, 64 (2), pp. 309-317
• Maggi, A., Abbadini, M., Pagella, P.G., Borowska, A., Pangrazzi, J., Donati, M.B., Antithrombotic properties of dermatan sulphate in a rat venous thrombosis model (1987) Haemostasis, 17 (6), pp. 329-335
• Van Ryn-McKenna, J., Weber, E.G.E., Ofosu, F.A., Buchanan, M.R., Effects of sulfated polysaccharides on inhibition of thrombus formation initiated by different stimuli (1989) Thrombosis and Haemostasis, 61 (1), pp. 7-9
• Carrie, D., Caranobe, C., Gabaig, A.M., Carroche, M., Boneu, B., Effects of heparin, dermatan sulphate and of their association on the inhibition of venous thrombosis growth in the rabbit (1992) Thromb Haemost, 68 (6), pp. 637-641
• Santoro, F.M., Alvarez, R., Fussi, F., Pharmacological profile of a native dermatan sulphate (1992) Thromb Res, 67 (2), pp. 201-211
• Van Ryn-McKenna, J., Ofosu, F.A., Gray, E., Hirsh, J., Buchanan, M.R., Effects of dermatan sulfate and heparin on inhibition of thrombus growth in vivo (1989) Annals of the New York Academy of Sciences, 556, pp. 304-312
• Abbadini, M., Zhu, G.J., Maggi, A., Pangrazzi, J., Donati, M.B., Mussoni, L., Dermatan sulphate induces plasminogen activator release in the perfused rat hindquarters (1987) Blood, 70 (6), pp. 1858-1860
• Barbanti, M., Calanni, F., Milani, M.R., Marchi, E., Semerano, N., Colucci, M., Therapeutic effect of a low molecular weight dermatan sulphate (Desmin 370) in rat venous thrombosis. Evidence for an anticoagulant-independent mechanism (1993) Thromb Haemost, 69 (2), pp. 147-151
• Colucci, M., Sardella, L., Barbanti, M., Calanni, F., Semeraro, N., Thrombolysis enhancing activity of a low molecular weight dermatan sulfate (Desmin 370) in experimental pulmonary embolism in rats (1997) Thrombosis Research, 87 (5), pp. 441-446. , DOI 10.1016/S0049-3848(97)00160-6, PII S0049384897001606
• Colucci, M., Rossiello, M.R., Barbanti, M., Calanni, F., Semeraro, N., Prevention and therapy of experimental venous thrombosis in rabbits by Desmin 370 (1998) Thrombosis and Haemostasis, 80 (2), pp. 338-341
• Barbanti, M., Calanni, F., Marchi, E., Semerano, N., Colucci, M., Desmin 370, a low molecular weight dermatan sul- Phate, reduces the weight of performed thrombi in rats made afibrinogenemic by ancrod (1995) Thromb Haemost, 73 (2), pp. 287-290
• Bell, W.R., Bolton, G., Pitney, C.R.M., The effect of ancrod on blood coagulation factors (1968) Br J Haematol, 15, pp. 589-602
• Tripodi, A., Moia, M., Bottasso, B., Tenconi, P.M., Gianese, F., Mannucci, P.M., Effects of subcutaneously administered dermatan sulfate (MF 701) on the coagulation and fibrinolytic parameters of healthy volunteers (1991) Thromb Res, 62 (6), pp. 663-672
• Dettori, A.G., Galli, G., Manotti, C., Palazzini, E., Pharmacological activity of a low molecular weight dermatan sulfate (desmin) in health volunteers (1994) Seminars in Thrombosis and Hemostasis, 20 (3), pp. 259-265
• Harenberg, J., Jeschek, M., Acker, M., Malsch, R., Huhle, G., Heene, D.L., Effects of low-molecular-weight dermatan sulfate on coagulation, fibrinolysis and tissue factor pathway inhibitor in healthy volunteers (1996) Blood Coagulation and Fibrinolysis, 7 (1), pp. 49-56
• Fri Berger, P., Knos, M., Gustavsson, S., Aurell, L., Claeson, G., Methods for determination of plasmin, antiplasmin and plasminogen by means of substrate S-2251 (1978) Haemostasis, 7, pp. 138-145
• Gaffney, P.J., Standards in fibrinolisis. Current status and future challenges (1995) Thromb Haemost, 74 (6), pp. 1389-1397
• Castanon, M.M., Gamba, C., Kordich, L.C., Insight into the profibrinolytic activity of dermatan sulfate: Effects on the activation of plasminogen mediated by tissue and urinary plasminogen activators (2007) Thrombosis Research, 120 (5), pp. 745-752. , DOI 10.1016/j.thromres.2006.12.014, PII S0049384806005226
• Castañon, M.M., Gamba, C., Kordich, L., Estudio in vitro de Ia acción del Dermatán Sulfato sobre la activación del plasminógeno por uroquinasa (2002) Acta Bioquím Clin Latinoam, 42 (SUPL 3), p. 85
• Castañon, M.M., Gamba, C., Kordich, L., Dermatán Sulfato como modulador de la activación de plasminógeno por t-PA XIX Congreso Internacional de Hemostasia y Trombosis (Grupo CLAHT) (2005) Viña Del Mar, Chile, 3 Al 6 de Noviembre de
• Gamba, C., Castañon, M.M., Kordich, L., Optimización de la reacción de activación de plasminógeno mediada por el activador tisular del plasminógeno (t-PA): Estimuladores solubles (2003) Medicina, 63 (2-5), p. 527
• Kyogashima, M., Onaya, J., Miyauchi, S., Arai, M., Shibata, Y., Suda, A., Antithrombotic activity of avian crown dermatan sulphate (1999) Thromb Res, 96, pp. 459-465
• Castañon, M., Kordich, L., Acción del Dermatán Sulfato de alto y bajo peso molecular sobre la actividad de plasmina in vitro (2001) XVII Congreso Internacional de Hemostasia y Trombosis (Grupo CLAHT)., , Ciudad de México, México, 6 al 9 de octubre de
• Paques, E.P., Stohr, H.A., Heimburger, N., Study on the mechanism of action of heparin and related substances on the fibrinolytic system: Relationship between plasminogen activators and heparin (1986) Thrombosis Research, 42 (6), pp. 797-807. , DOI 10.1016/0049-3848(86)90116-7
• Takada, Y., Urano, T., Takada, A., Effects of heparan sulfate analogue or other sulfated polysaccharides on the activation of plasminogen by t-PA or u-PA (1994) Thrombosis Research, 73 (5), pp. 301-311. , DOI 10.1016/0049-3848(94)90026-4
• Edelberg, J.M., Weissler, M., Pizzo, S.V., Kinetic analysis of the effects of glycosaminoglycans and lipoproteins on urokinase-mediated plasminogen activation (1991) Biochem J, 276, pp. 785-791
• Rydzewski, A., Takada, Y., Takada, A., Stimulation of plasmin catalyzed conversion of single-chain to two-chain urokinase-type plasminogen activator by sulfated polysaccharides (1989) Thrombosis and Haemostasis, 62 (2), pp. 752-755
• Dosne, A.M., Bendetowicz, A.V., Kher, A., Samama, M., Marked potentiation of the plasminogenolytic activity of pro-urokinase by unfractionated heparin and a low molecular-weight heparin (1988) Thrombosis Research, 51 (6), pp. 627-630. , DOI 10.1016/0049-3848(88)90146-6
• Andrade-Gordon, P., Strickland, S., Interaction of heparin with plasminogen activators and plasminogen: Effects on the activation of plasminogen (1986) Biochemistry, 25 (14), pp. 4033-4040
• Edelberg, J.M., Pizzo, S.V., Kinetic analysis of the effects of heparin and lipoproteins on the tissue plasminógeno activator mediated plasminógeno activation (1990) Biochemistry, 29, pp. 5906-5911
• Bertolesi, G.E., Farias, E.F., Alonso, D.F., De Kier, B., Joffe, E., Lauria De Cidre, S., Eiján, A.M., Insight into the profibrinolytic activity of heparin: Effects on the activation of plasminógeno mediated by urokinase (1997) Blood Coagul Fibrinolysis, 8, pp. 403-410
• Mantel, W.F., Lin, B.H., Ramakrishnan, V., Characterization o fan extremely large, ligand-induced conformational change in plasminogen (1999) Science, 248 (4951), pp. 69-73
• Holvoet, P., Lijnen, H.R., Collen, D., A monoclonal antibody specific for Lys-plasminogen (1985) J Biol Chem, 260 (22), pp. 12106-12111
• Takada, A., Takada, Y., Sugawara, Y., Effects of fibrinogen and fibrin on the activation of GLU- And LYS-plasminogen by urokinase (1984) Thrombosis Research, 33 (6), pp. 561-569
• Castañon, M.M., Kordich, L., Efecto del Dermatán Sulfato sobre la activación de Lys-plasminógeno mediada por u-PA y t-PA (2006) Acta Bioquím Clin Latinoam, 40 (SUPL 5), p. 64
• Tillett, W.S., Garner, R.L., The fibrinolytic activity of hemolytic streptococci (1933) J Exp Med, 68, pp. 4885-5502
• Castañon, M.M., Gamba, C., Kordich, L., Dermatán Sulfato como modulador de la activación de plasminógeno por estreptoquinasa (2003) Medicina, 63 (2-5), p. 553
• Loy, J.A., Lin, X., Schenone, M., Castellino, F.J., Zhang, X.C., Tang, J., Domain interactions between streptokinase and human plasminogen (2001) Biochemistry, 40 (48), pp. 14686-14695. , DOI 10.1021/bi011309d
• Bean, R.R., Verhamme, I.M., Bock, P.E., Role of the streptokinase alpha-domain in the interactions of streptoki-nase with plasminogen and plasmin (2005) J Biol Chem, 280 (9), pp. 7504-7510
• Stein, P.L., Van Zonneveld, A.J., Pannekoek, H., Strickland, S., Structural domains of human tissue-type plasminogen activator that confer stimulation by heparin (1989) Journal of Biological Chemistry, 264 (26), pp. 15441-15444
• Stephens, R.W., Bokman, A.M., Myohanen, H.T., Reisberg, T., Tapiovaara, H., Pedersen, N., Heparin binding to the urokinase kringle domain (1992) Biochem, 31, pp. 7572-7579
• Soeda, S., Kakiki, M., Shimeno, H., Nagamatsu, A., Localization of the binding sites of porcine tissue-type plasminógeno activator and plasminogen to heparin (1987) Biochim Biophys Acta, 916 (3), pp. 279-287
• Liang, J.F., Li, Y., Yang, V., The potential mechanism for the effect of heparin on tissue plasminogen activator-mediated plasminogen activation (2000) Thrombosis Research, 97 (5), pp. 349-358. , DOI 10.1016/S0049-3848(99)00188-7, PII S0049384899001887
• Andrade-Gordon, P., Strickland, S., Anticoagulant low molecular weight heparin does not enhance the activation of plasminogen by tissue plasminogen activator (1989) Journal of Biological Chemistry, 264 (26), pp. 15177-15181
• Edelberg, J.M., Weissler, M., Pizzo, S.V., Heparin oligosaccharides enhance t-PA: A correlation between oligosaccharide length and stimulation of plasminogen activation (1991) Biochem, 30, pp. 10999-11003
• Lauricella, A.M., Castañon, M.M., Gamba, C., Usach, V., Kordich, L., Efecto del Dermatán Sulfato en la formación y lisis de redes de fibrina (2003) Medicina, 63 (2-5), p. 655
• Castañon, M.M., Lauricella, A.M., Kordich, L., Efecto profibrinolítico del dermatán sulfato: Modificación de la estructura y lisabilidad de la red de fibrina (2008) Acta Bioquím Clín Latinoam, 42 (SUPL 1), p. 190
• Carr, M.E., Powers, P.L., Effect of glycosaminoglycans on thrombin- And atroxin- induced fibrin assembly and structure (1989) Thromb Haemost, 62 (4), pp. 1057-1061
• Nair, A.H., Shah, G.A., Dhall, D.P., Effect of temperature, pH and ionic strength and composition on fibrin network structure and its development (1986) Thromb Res, 42, pp. 809-816
• Okada, M., Blomback, B., Calcium and fibrin structure (1983) Thromb Res, 29 (3), pp. 269-280
• Blomback, B., Carlsson, K., Hessel, B., Liljeborg, A., Procyk, R., Aslund, N., Native fibrin gel networks observed by 3D microscopy, permeation and turbidity (1989) Biochimica et Biophysica Acta - Protein Structure and Molecular Enzymology, 997 (1-2), pp. 96-110
• Nair, A.H., Azhar, A., Dhall, D.P., The effect of some plasma proteins on fibrin network structure (1991) Blood Coagul Fibrinol, 1 (4-5), pp. 469-473
• Elgue, G., Sanchez, J., Fatah, K., Olsson, P., Blomback, B., The effect of plasma antithrombin concentration on thrombin generation and fibrin gel structure (1994) Thrombosis Research, 75 (2), pp. 203-212. , DOI 10.1016/0049-3848(94)90069-8
• Nair, C.H., Shats, E.A., Compaction as a method to characterize fibrin network structure: Kinetic studies and relationship to crosslinking (1997) Thromb Res, 88, pp. 381-387
• Nair, A.H., Azhar, A., Dhall, D.P., Studies on fibrin network structure in human plasma (1991) Part One: Methods for Clinical Application. Thromb Res, 64, pp. 455-476
• Sugo, T., Nakamikawa, C., Yoshida, N., Niwa, K., Sameshima, M., Mimuro, J., End-linked homodimers in fibrinogen Osaka VI with a B beta-chain extension lead to fragile clot structure (2000) Blood, 96 (12), pp. 3779-3785
• Lauricella, A.M., Variabilidad de las redes de fibrina (2007) Acta Bioquím Clín Latinoam, 41 (1), pp. 7-19
• Jones, M., Gabriel, D.A., Influence of subendothelial basement membrana components on fibrin assembly (1988) J Biol Chem, 263 (15), pp. 7043-7048
• Collen, A., Smorenburg, S.M., Peters, E., Lupu, F., Koolwijk, P., Van Noorden, C., Unfraccionated and low molecular weight heparin structure and angiogenesis (2000) In Vitro. Cancer Res, 60, pp. 6196-6200
• Collet, J.P., Mishal, Z., Vasse, M., Mirshahi, M., Caen, J.P., Soria, C., Soria, J., Pharmacological approaches of fibrin gel architecture modulation and thrombus degradation: Its implication in atherogenesis and thromboembolism disease (1994) Thrombosis Research, 75 (3), pp. 353-359. , DOI 10.1016/0049-3848(94)90250-X
• Weisel, J., Veklich, Y., Collet, J., Francise, W., Structural studies of fibrinolysis by electron and light microscopy (1999) Thromb Haemost, 82 (2), pp. 277-282
• Collet, J.P., Park, D., Lestyc, C., Soria, J., Soria, C., Montalescot, G., Influence of fibrin network conformation and fibrin fibre diameter on fibrinolysos speed. Dynamic and structural approaches by confocal microscopy (2000) Arteriocler Thromb Vase Biol, 20, pp. 1354-1361
• Dugan, T.A., Yang, V.W., BcQuillan, D.J., Hook, M., Decorin modulates fibrin assembly and structure (2006) Journal of Biological Chemistry, 281 (50), pp. 38208-38216. , http://www.jbc.org/cgi/reprint/281/50/38208, DOI 10.1074/jbc.M607244200
• Varin, R., Mirshahi, S., Mirshahi, P., Kierzek, G., Sebaoun, D., Mishal, Z., Vannier, J.P., Soria, J., Clot structure modification by fondaparinux and consequence on fibrinolysis: A new mechanism of antithrombotic activity (2007) Thrombosis and Haemostasis, 97 (1), pp. 27-31. , DOI 10.1160/TH06-07-0394
• Fearnley, G., Balm, F., Fearnley, E., Evidence of diurnal fibrinolytic rhythm with a simple method of measuring natural fibrinolysis (1957) Clin Science, 16, pp. 645-647
• Kowalski, E., Kopec, M., Niewiarowski, S., An evaluation of the euglobulin method for the determination of fibrinolysis (1959) J Clin Pathol, 12, p. 215
• Onaya, J., Kyogashima, M., Sakai, T., Dermatan sulfate as a bifunctional antithrombotic (1999) Cardiovasc Drugs Rev, 17 (3), pp. 225-236
• Dong, Q.G., Bernasconi, S., Lostaglio, S., De Calmanovia, R.W., Martin-Padura, I., Breviario, F., A general strategy for isolation of endothelial cells from murine tissues. Characterization of two endothelial cells lines from the murine lung and subcutaneous sponge implants (1997) Arterioscler Thromb Vase Biol, 17 (8), pp. 1599-1604
• Du, H.Y., Ji, S.L., Song, H.F., Ye, Q.N., Cao, J.C., The relationship between the structure of dermatan sulfate derivatives and their antithrombotic activities (2007) Thromb Res, 119 (3), pp. 377-384
• Marsh, N.A., Minter, A.J., Chesterman, C.N., The effect of heparin and other glyeosaminoglycans on levels of tissue plasminogen activator and plasminogen activator inhibitor in cultured human umbilical vein endothelial cells (1990) Blood Coag Fibrinol, 1 (2), pp. 133-138
• Krupinski, K., Bielawiec, M., Yoshida, K., Kyogashima, M., Takada, Y., Takada, A., Dermatan sulfate enhances the lysis of laser-induced thrombus in vivo (1998) Thrombosis Research, 91 (4), pp. 199-202. , DOI 10.1016/S0049-3848(98)00077-2, PII S0049384898000772
• Rossi, E., Kordich, L., Niveles plasmáticos e interacciones del sistema Cofactor II de la Heparina-Trombina- Dermatán Sulfato (tesis doctoral) (1999) Buenos Aires, Universidad de Buenos Aires
• Giri, T.K., Tollefsen, D.M., Placental dermatán sulfate: Isolation, anticoagulant activity, and association with heparin cofactor II (2006) Blood, 107 (7), pp. 2753-2758
• Brennan, M.J., Oldberg, A., Pierschbacher, M.D., Ruoslahti, E., Chondroitin/dermatan sulfate proteoglycan in human fetal membranes. Demonstration of an antigenically similar proteoglycan in fibroblasts (1984) Journal of Biological Chemistry, 259 (22), pp. 13742-13750
• Brenner, B., Haemostatic changes in pregnancy (2004) Thrombosis Research, 114, pp. 409-414
• Bellart, J., Gilabert, R., Cabero, L., Fontcuberta, J., Monasterio, J., Miralles, R.M., Heparin cofactor II: A new marker for pre-eclampsia (1998) Blood Coagulation and Fibrinolysis, 9 (2), pp. 205-208
• Warda, M., Zhang, F., Radwan, M., Zhang, Z., Kim, N., Kim, Y.N., Is human placenta proteoglycan remodeling involved in pre-eclampsia? (2008) Gycocoj J, 25 (5), pp. 441-450
• Koh, C.L., Enhanced PAI-1 levels from early second trimester and during labour and plasminogen activators in normal pregnancy (2002) Thromb Haemost, 87, pp. 175-176
• Hellgren, M., Hemostasis during normal pregnancy and Puerperium (2003) Sem Thromb Hemost, 29 (2), pp. 125-130

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------